220 related articles for article (PubMed ID: 33470085)
1. Factors associated with time to sputum culture conversion of rifampicin-resistant tuberculosis patients in Klaipeda, Lithuania in 2016-2019: a cohort study.
Diktanas S; Korotych O; Sereda Y; Gozalov O; Rubcova O; Achar J
Monaldi Arch Chest Dis; 2021 Jan; 91(1):. PubMed ID: 33470085
[TBL] [Abstract][Full Text] [Related]
2. Time to sputum smear and culture conversions in multidrug resistant tuberculosis at University of Gondar Hospital, Northwest Ethiopia.
Shibabaw A; Gelaw B; Wang SH; Tessema B
PLoS One; 2018; 13(6):e0198080. PubMed ID: 29944658
[TBL] [Abstract][Full Text] [Related]
3. Treatment outcomes of patients with multidrug-resistant and extensively drug resistant tuberculosis in Hunan Province, China.
Alene KA; Yi H; Viney K; McBryde ES; Yang K; Bai L; Gray DJ; Clements ACA; Xu Z
BMC Infect Dis; 2017 Aug; 17(1):573. PubMed ID: 28814276
[TBL] [Abstract][Full Text] [Related]
4. Association between Regimen Composition and Treatment Response in Patients with Multidrug-Resistant Tuberculosis: A Prospective Cohort Study.
Yuen CM; Kurbatova EV; Tupasi T; Caoili JC; Van Der Walt M; Kvasnovsky C; Yagui M; Bayona J; Contreras C; Leimane V; Ershova J; Via LE; Kim H; Akksilp S; Kazennyy BY; Volchenkov GV; Jou R; Kliiman K; Demikhova OV; Vasilyeva IA; Dalton T; Cegielski JP
PLoS Med; 2015 Dec; 12(12):e1001932. PubMed ID: 26714320
[TBL] [Abstract][Full Text] [Related]
5. Factors associated with culture conversion among adults treated for pulmonary extensively drug-resistant tuberculosis during 2018-2019 in the Russian Federation: an observational cohort study.
Russkikh A; Korotych O; Sereda Y; Samoilova A; Achar J; Yedilbayev A; Dara M; Vasilyeva I
Monaldi Arch Chest Dis; 2021 Jan; 91(1):. PubMed ID: 33470087
[TBL] [Abstract][Full Text] [Related]
6. Diabetes mellitus, smoking status, and rate of sputum culture conversion in patients with multidrug-resistant tuberculosis: a cohort study from the country of Georgia.
Magee MJ; Kempker RR; Kipiani M; Tukvadze N; Howards PP; Narayan KM; Blumberg HM
PLoS One; 2014; 9(4):e94890. PubMed ID: 24736471
[TBL] [Abstract][Full Text] [Related]
7. Predictors of sputum culture conversion time among MDR/RR TB patients on treatment in a low-income setting.
Meshesha MD
PLoS One; 2022; 17(11):e0277642. PubMed ID: 36374857
[TBL] [Abstract][Full Text] [Related]
8. Determinants of sputum culture conversion time in multidrug-resistant tuberculosis patients in ALERT comprehensive specialized hospital, Addis Ababa, Ethiopia: A retrospective cohort study.
Abebe M; Atnafu A; Tilahun M; Sero N; Neway S; Alemu M; Tesfaye G; Mihret A; Bobosha K; Wan C
PLoS One; 2024; 19(5):e0304507. PubMed ID: 38820260
[TBL] [Abstract][Full Text] [Related]
9. Prevalence, Predictors, and Successful Treatment Outcomes of Xpert MTB/RIF-identified Rifampicin-resistant Tuberculosis in Post-conflict Eastern Democratic Republic of the Congo, 2012-2017: A Retrospective Province-Wide Cohort Study.
Bulabula ANH; Nelson JA; Musafiri EM; Machekano R; Sam-Agudu NA; Diacon AH; Shah M; Creswell J; Theron G; Warren RM; Jacobson KR; Chirambiza JP; Kalumuna D; Bisimwa BC; Katoto PDMC; Kaswa MK; Birembano FM; Kitete L; Grobusch MP; Kashongwe ZM; Nachega JB
Clin Infect Dis; 2019 Sep; 69(8):1278-1287. PubMed ID: 30759187
[TBL] [Abstract][Full Text] [Related]
10. Body mass index predictive of sputum culture conversion among MDR-TB patients in Indonesia.
Putri FA; Burhan E; Nawas A; Soepandi PZ; Sutoyo DK; Agustin H; Isbaniah F; Dowdy DW
Int J Tuberc Lung Dis; 2014 May; 18(5):564-70. PubMed ID: 24903794
[TBL] [Abstract][Full Text] [Related]
11. Culture Conversion in Patients Treated with Bedaquiline and/or Delamanid. A Prospective Multicountry Study.
Franke MF; Khan P; Hewison C; Khan U; Huerga H; Seung KJ; Rich ML; Zarli K; Samieva N; Oyewusi L; Nair P; Mudassar M; Melikyan N; Lenggogeni P; Lecca L; Kumsa A; Khan M; Islam S; Hussein K; Docteur W; Chumburidze N; Berikova E; Atshemyan H; Atwood S; Alam M; Ahmed S; Bastard M; Mitnick CD
Am J Respir Crit Care Med; 2021 Jan; 203(1):111-119. PubMed ID: 32706644
[No Abstract] [Full Text] [Related]
12. Time to sputum culture conversion in multidrug-resistant tuberculosis: predictors and relationship to treatment outcome.
Holtz TH; Sternberg M; Kammerer S; Laserson KF; Riekstina V; Zarovska E; Skripconoka V; Wells CD; Leimane V
Ann Intern Med; 2006 May; 144(9):650-9. PubMed ID: 16670134
[TBL] [Abstract][Full Text] [Related]
13. Unacceptable treatment outcomes and associated factors among India's initial cohorts of multidrug-resistant tuberculosis (MDR-TB) patients under the revised national TB control programme (2007-2011): Evidence leading to policy enhancement.
Parmar MM; Sachdeva KS; Dewan PK; Rade K; Nair SA; Pant R; Khaparde SD
PLoS One; 2018; 13(4):e0193903. PubMed ID: 29641576
[TBL] [Abstract][Full Text] [Related]
14. Predictors of time to unfavorable treatment outcomes among patients with multidrug resistant tuberculosis in Oromia region, Ethiopia.
Woldeyohannes D; Assefa T; Aman R; Tekalegn Y; Hailemariam Z
PLoS One; 2019; 14(10):e0224025. PubMed ID: 31665154
[TBL] [Abstract][Full Text] [Related]
15. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis].
Saito W; Nagayama N; Miyamoto M; Hara H; Suzuki J; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Yotsumoto H
Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568
[TBL] [Abstract][Full Text] [Related]
16. Factors associated with unfavourable treatment outcomes among people with rifampicin-resistant tuberculosis in Armenia, 2014-2017.
Khachatryan L; Grigoryan R; Dadu A; Kumar AMV; Akopyan K; Dumchev K; Harutyunyan H; Matteelli A
Monaldi Arch Chest Dis; 2021 Jan; 91(1):. PubMed ID: 33470086
[TBL] [Abstract][Full Text] [Related]
17. Fluroquinolone drug resistance among MDR-TB patients increases the risk of unfavourable interim microbiological treatment outcome: An observational study.
Singh N; Singh PK; Singh U; Garg R; Jain A
J Glob Antimicrob Resist; 2021 Mar; 24():40-44. PubMed ID: 33279685
[TBL] [Abstract][Full Text] [Related]
18. Pyrazinamide may improve fluoroquinolone-based treatment of multidrug-resistant tuberculosis.
Chang KC; Leung CC; Yew WW; Leung EC; Leung WM; Tam CM; Zhang Y
Antimicrob Agents Chemother; 2012 Nov; 56(11):5465-75. PubMed ID: 22869570
[TBL] [Abstract][Full Text] [Related]
19. Long-term treatment outcomes in patients with multidrug-resistant tuberculosis.
Maier C; Chesov D; Schaub D; Kalsdorf B; Andres S; Friesen I; Reimann M; Lange C
Clin Microbiol Infect; 2023 Jun; 29(6):751-757. PubMed ID: 36842637
[TBL] [Abstract][Full Text] [Related]
20. Time to sputum culture conversion and its determinants among Multi-drug resistant Tuberculosis patients at public hospitals of the Amhara Regional State: A multicenter retrospective follow up study.
Yihunie Akalu T; Muchie KF; Alemu Gelaye K
PLoS One; 2018; 13(6):e0199320. PubMed ID: 29927980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
